The Government has introduced emergency legislation with the aim of banning reproductive
cloning. The Government considers that there is a need for this change in the law as a
result of a High Court judgement on 15 November which established that embryos created
other than by fertilisation are not regulated by the 1990 Human Fertilisation and
Embryology Act. This is an outcome that the Science and Technology Select Committee warned
the Government against in 1997 (More details about this are outlined in the press release I recently issued on the subject.) The Select
Committee recommended that the Government should change the definition of embryo in the
HFE Act to make it clear that it includes those created by cell nuclear replacement
(cloning) or any manipulation of cells which results in an organism potentially capable of
growing into a human, and not just conventional fertilisation. This would have the effect
of ensuring that all research on embryos, however created, was fully regulated by the
Human Fertilisation and Embryology Authority. However, the Government has rejected this
approach. An appeal is being lodged against the High Court judgement and although there is
no imminent threat of cloned embryos being created nor of resultant cloned babies being
born, the Government is introducing emergency legislation. The Human Reproductive Cloning
Bill has been introduced in the Lords and will be considered by the Commons on Thursday 29
November.
The legislation places a complete ban on Human Reproductive Cloning which will become
an offence, punishable by up to 10 years imprisonment or a fine, or both, if a person
places in a woman any embryo that has not been created by fertilisation (using sperm and
eggs). Whilst I support this legislation in principle, as I agree human reproductive
cloning should be banned, unless the Government is successful in its appeal, it will still
be necessary to revisit the issue of "therapeutic" cloning which, in the light
of the High Court judgement, is currently unregulated.
The Governments position on the use of embryos created by cell nuclear
replacement for research (therapeutic cloning) is to await the result of its appeal and
also the publication of the Report of the House of Lords Select Committee on stem cell
research.
SHOULD EMBRYOS BE USED FOR RESEARCH?
by Lynne Jones MP
November 2001
The Human Fertilisation and Embryology Act, 1990 is the law which was introduced
originally to govern the creation of embryos from in vitro fertilisation (IVF)
treatment for infertility and what research can be done on those embryos. IVF treatment
inevitably creates more test tube embryos than can safely be implanted into the mother. In
the 8 years after the 1990 Act, with the permission of the donors, almost 50,000 embryos
were given to researchers from the more than 750,000 produced from women undergoing IVF
programmes. 250,000 were destroyed.
Research on embryos is permitted up to 14 days after fertilisation and requires
approval and a licence from the Human Fertilisation and Embryology Authority (HFEA) set up
under the 1990 Act to strictly regulate these matters. The 14 day cut-off is based on the
earliest time at which the microscopic clump of cells starts to form the beginnings of
what would eventually turn into the central nervous system. Up to that stage, the embryo
is a hollow ball of about 100 cells, called a blastocyst, smaller than a full stop. The
component cells are called stem cells because they have not differentiated but each one
has the potential to develop into the different cell types which make up the body.
The purposes for which such research is permitted were set out in a list in the HFE Act
and it was always envisaged that this could be added to by secondary legislation. The
original list included infertility and contraception. Since 1990, research has opened up
the possibility of using early embryonic cells to investigate how mature cells can be
reprogrammed to the more immature state found in stem cells and made to turn into
replacement cells or tissue for diseased organs. The cells used for this research can
continue to be derived from IVF treatment or could be blastocysts "cloned" from
the nucleus of an adult cell and a human egg cell from which its own nuclear DNA has been
removed. The eggs used could only be taken with the consent of a woman donor, most likely
a woman undergoing fertility treatment.
Both the HFEA, the Human Genetics Commission and the Donaldson Committee, expert groups
set up by the Government, have now concluded that this type of research does not raise
fundamentally new ethical issues than those debated when the 1990 Act was introduced. The
Act was amended in December 2000 to broaden the range of research that will be permitted
to include stem cell studies that have the aim of treating disease and disorders.
Despite warnings from the Science and
Technology Select Committee the Government, on legal advice, took the view that
reproductive cloning (the creation of a viable human life) was already technically illegal
but stated its intention to legislate to make it specifically illegal. There is no
clinical reason why society would wish to make a genetic copy of a person and to attempt
to do so would be extremely difficult and dangerous.
Opponents of the use of embryonic stem cells have pointed out that stem cells can be
derived from other sources, notably blood cells taken from the umbilical cord at the time
of birth and some adult tissue. These stem cells hold real promise but there are some
significant limitations to what can be accomplished with them. The expert groups took the
view that the understanding that will come from studying the process of differentiation in
embryonic stem cells will enable the techniques that are only presently possible with
embryonic stem cells to be possible with stem cells from adult tissue or cord blood. In
licensing any research using embryos the HFEA must satisfy itself that there are no other
means of meeting the objectives of the research. If the research is successful, it will be
possible to derive all stem cells needed through direct conversion of a patients
skin cells without the need to use embryos. However, as the only source of appropriate
stem cells at present is from early embryos, some limited research work on embryonic
tissue is essential if we are to achieve an understanding of the conditions under which
cells can be programmed.
The Association of Medical Research Charities and the Parkinsons Disease Society
are strongly in favour of the research which could lead to breakthroughs in the treatment
of many debilitating conditions but "pro-life" groups are opposed strongly
citing a European Parliament vote in favour of a ban on stem cell research. However, the
EU motion also opposes the IVF techniques mentioned above that have been permitted in this
country since the 1990 Act. Almost all Labour, Tory and Liberal Democrat MEPs opposed the
Christian Democrat motion. Furthermore, the European Union does not have legislative
competence in the area of scientific research, and so this Resolution acts to express an
ethical opinion only.
Fundamentalists will continue to argue that at the moment of fertilisation, a potential
person is born. Yet, ever since the birth of Dolly the sheep, we have known
that all the cells in the body have the potential to be unique individuals. As I see it,
the rights of a patient who would benefit from stem cell research are more important than
the rights of a pre-implantation embryo that lacks a brain, a heart or any recognisable
feature. I look forward to the day when we will be able to take an adult cell, say from a
speck of skin, and re-programme it so that it becomes equivalent to an embryonic stem cell
which can then be converted to cells and tissues for transplant. In the end, I would like
to think that both sides of the debate will share this view and welcome the possibility of
being able to grow a patients own tissue without the need to clone embryos at all. |